[1]
B. Pawlicki, A. Biernasiuk, M. Jonczyk, and A. Malm, “Susceptibility in vitro of clinical Candida albicans isolates to the selected azoles”, Curr. Issues Pharm. Med. Sci., vol. 34, no. 2, pp. 77–80, Jun. 2021, doi: 10.2478/cipms-2021-0015.